Tofacitinib citrate
99%
- Product Code: 103388
CAS:
540737-29-9
| Molecular Weight: | 504.49 g./mol | Molecular Formula: | C₁₆H₂₀N₆OC₆H₈O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11616529 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Tofacitinib citrate is primarily used in the treatment of autoimmune conditions, particularly rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by inhibiting the Janus kinase (JAK) enzymes, which play a key role in the immune response and inflammation. This helps reduce symptoms such as joint pain, swelling, and stiffness in arthritis patients. In ulcerative colitis, it aids in managing inflammation in the digestive tract, improving bowel function and reducing flare-ups. Additionally, it is sometimes prescribed for other autoimmune disorders where traditional therapies have been ineffective. Its oral administration offers convenience for patients requiring long-term management of chronic inflammatory conditions.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Beige Solid |
| Purity (%) | 98.5-100 |
| Solubility | DMSO: 5 Mg/Ml (Clear Solution; Warmed) |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 | 10-20 days | ฿1,350.00 |
+
-
|
| 1.000 | 10-20 days | ฿4,700.00 |
+
-
|
| 5.000 | 10-20 days | ฿19,290.00 |
+
-
|
Tofacitinib citrate
Tofacitinib citrate is primarily used in the treatment of autoimmune conditions, particularly rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by inhibiting the Janus kinase (JAK) enzymes, which play a key role in the immune response and inflammation. This helps reduce symptoms such as joint pain, swelling, and stiffness in arthritis patients. In ulcerative colitis, it aids in managing inflammation in the digestive tract, improving bowel function and reducing flare-ups. Additionally, it is sometimes prescribed for other autoimmune disorders where traditional therapies have been ineffective. Its oral administration offers convenience for patients requiring long-term management of chronic inflammatory conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :